Annual long term debt:
$626.39M-$4.82M(-0.76%)Summary
- As of today (September 13, 2025), BMRN annual long term debt is $626.39 million, with the most recent change of -$4.82 million (-0.76%) on December 31, 2024.
- During the last 3 years, BMRN annual long term debt has fallen by -$486.52 million (-43.72%).
- BMRN annual long term debt is now -44.05% below its all-time high of $1.12 billion, reached on December 31, 2020.
Performance
BMRN Long term debt Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Highlights
Range
Earnings dates
Quarterly long term debt:
$596.16M+$512.00K(+0.09%)Summary
- As of today (September 13, 2025), BMRN quarterly long term debt is $596.16 million, with the most recent change of +$512.00 thousand (+0.09%) on June 30, 2025.
- Over the past year, BMRN quarterly long term debt has increased by +$2.05 million (+0.34%).
- BMRN quarterly long term debt is now -48.87% below its all-time high of $1.17 billion, reached on September 30, 2017.
Performance
BMRN Quarterly long term debt Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Highlights
Range
Earnings dates
Long term debt Formula
Long-Term Debt = Bonds Payable + Long-Term Loans + Mortgage Payable + Other Long-Term Borrowings − Current Portion of Long-Term Debt
BMRN Long term debt Trends
PeriodPeriod | AnnualAnnual | QuarterlyQuarterly |
---|---|---|
1 y1 year | -0.8% | +0.3% |
3 y3 years | -43.7% | -44.9% |
5 y5 years | +16.6% | -46.8% |
BMRN Long term debt Highs & Lows
PeriodPeriod | Annual vs highAnnual vs high | Annual vs lowAnnual vs low | Quarter. vs highQuarter. vs high | Quarter. vs lowQuarter. vs low | |
---|---|---|---|---|---|
3 y | 3-year | -43.7% | at low | -46.3% | +0.6% |
5 y | 5-year | -44.0% | +16.6% | -46.8% | +0.6% |
alltime | all time | -44.0% | >+9999.0% | -48.9% | >+9999.0% |
BMRN Long term debt History
Date | Annual | Quarterly |
---|---|---|
Jun 2025 | - | $596.16M(+0.1%) |
Mar 2025 | - | $595.65M(-4.9%) |
Dec 2024 | $626.39M(-0.8%) | $626.39M(+5.3%) |
Sep 2024 | - | $594.63M(+0.1%) |
Jun 2024 | - | $594.12M(+0.1%) |
Mar 2024 | - | $593.61M(-6.0%) |
Dec 2023 | $631.22M(-43.1%) | $631.22M(+6.5%) |
Sep 2023 | - | $592.59M(-45.4%) |
Jun 2023 | - | $1.08B(+0.1%) |
Mar 2023 | - | $1.08B(-2.3%) |
Dec 2022 | $1.11B(-0.3%) | $1.11B(+2.5%) |
Sep 2022 | - | $1.08B(+0.1%) |
Jun 2022 | - | $1.08B(+0.1%) |
Mar 2022 | - | $1.08B(-3.0%) |
Dec 2021 | $1.11B(-0.6%) | $1.11B(+3.2%) |
Sep 2021 | - | $1.08B(+0.1%) |
Jun 2021 | - | $1.08B(+0.1%) |
Mar 2021 | - | $1.08B(-3.9%) |
Dec 2020 | $1.12B(+108.5%) | $1.12B(+0.0%) |
Sep 2020 | - | $1.12B(-0.0%) |
Jun 2020 | - | $1.12B(+108.5%) |
Mar 2020 | - | $537.09M(+0.0%) |
Dec 2019 | $537.04M(-35.3%) | $537.04M(-40.2%) |
Sep 2019 | - | $898.66M(+0.6%) |
Jun 2019 | - | $893.04M(+1.2%) |
Mar 2019 | - | $882.72M(+6.3%) |
Dec 2018 | $830.42M(+2.1%) | $830.42M(+0.5%) |
Sep 2018 | - | $826.12M(+0.5%) |
Jun 2018 | - | $821.87M(+0.5%) |
Mar 2018 | - | $817.67M(+0.5%) |
Dec 2017 | $813.52M(+23.1%) | $813.52M(-30.2%) |
Sep 2017 | - | $1.17B(+72.4%) |
Jun 2017 | - | $676.21M(+1.2%) |
Mar 2017 | - | $668.44M(+1.2%) |
Dec 2016 | $660.76M(-0.2%) | $660.76M(+1.2%) |
Sep 2016 | - | $653.18M(+1.2%) |
Jun 2016 | - | $645.68M(-3.3%) |
Mar 2016 | - | $668.01M(+0.9%) |
Dec 2015 | $662.29M(+0.7%) | $662.29M(-0.8%) |
Sep 2015 | - | $667.79M(+1.0%) |
Jun 2015 | - | $661.49M(+0.9%) |
Mar 2015 | - | $655.49M(-0.4%) |
Dec 2014 | $657.98M(+0.4%) | $657.98M(+0.2%) |
Sep 2014 | - | $656.88M(+0.9%) |
Jun 2014 | - | $650.87M(-1.6%) |
Mar 2014 | - | $661.42M(+0.9%) |
Dec 2013 | $655.57M(+101.8%) | $655.57M(+737.1%) |
Sep 2013 | - | $78.31M(-28.7%) |
Jun 2013 | - | $109.82M(-0.0%) |
Mar 2013 | - | $109.85M(-66.2%) |
Dec 2012 | $324.86M(-6.7%) | $324.86M(-0.0%) |
Sep 2012 | - | $324.86M(-0.0%) |
Jun 2012 | - | $324.87M(-0.0%) |
Mar 2012 | - | $324.87M(-6.7%) |
Date | Annual | Quarterly |
---|---|---|
Dec 2011 | $348.33M(-7.7%) | $348.33M(-0.0%) |
Sep 2011 | - | $348.34M(-7.7%) |
Jun 2011 | - | $377.52M(-0.0%) |
Mar 2011 | - | $377.52M(0.0%) |
Dec 2010 | $377.52M(-24.1%) | $377.52M(-24.1%) |
Sep 2010 | - | $497.08M(0.0%) |
Jun 2010 | - | $497.08M(0.0%) |
Mar 2010 | - | $497.08M(-0.0%) |
Dec 2009 | $497.17M(-0.0%) | $497.17M(+0.0%) |
Sep 2009 | - | $497.08M(-0.0%) |
Jun 2009 | - | $497.26M(-0.0%) |
Mar 2009 | - | $497.31M(-0.0%) |
Dec 2008 | $497.35M(-0.0%) | $497.35M(-0.2%) |
Sep 2008 | - | $498.44M(+0.2%) |
Jun 2008 | - | $497.44M(+0.0%) |
Mar 2008 | - | $497.30M(-0.0%) |
Dec 2007 | $497.38M(+122.1%) | $497.38M(0.0%) |
Sep 2007 | - | $497.38M(0.0%) |
Jun 2007 | - | $497.38M(+188.3%) |
Mar 2007 | - | $172.50M(-23.0%) |
Dec 2006 | $223.94M(+57.6%) | $223.94M(0.0%) |
Sep 2006 | - | $223.94M(-24.7%) |
Jun 2006 | - | $297.50M(0.0%) |
Mar 2006 | - | $297.50M(+109.4%) |
Dec 2005 | $142.05M(+0.5%) | $142.05M(-0.7%) |
Sep 2005 | - | $143.01M(-0.7%) |
Jun 2005 | - | $143.98M(-0.4%) |
Mar 2005 | - | $144.60M(+2.3%) |
Dec 2004 | $141.41M(+12.5%) | $141.41M(+7.1%) |
Sep 2004 | - | $131.99M(+2.5%) |
Jun 2004 | - | $128.78M(+3.0%) |
Mar 2004 | - | $125.00M(-0.5%) |
Dec 2003 | $125.67M(+3614.8%) | $125.67M(+0.5%) |
Sep 2003 | - | $125.00M(0.0%) |
Jun 2003 | - | $125.00M(+2680.2%) |
Mar 2003 | - | $4.50M(+32.9%) |
Dec 2002 | $3.38M(-14.6%) | $3.38M(>+9900.0%) |
Sep 2002 | - | $0.00(0.0%) |
Jun 2002 | - | $0.00(-100.0%) |
Mar 2002 | - | $3.50M(-11.6%) |
Dec 2001 | $3.96M(+6973.2%) | $3.96M(+2613.0%) |
Sep 2001 | - | $146.00K(-26.3%) |
Jun 2001 | - | $198.00K(+321.3%) |
Mar 2001 | - | $47.00K(-16.1%) |
Dec 2000 | $56.00K(-34.1%) | $56.00K(-11.1%) |
Sep 2000 | - | $63.00K(-7.4%) |
Jun 2000 | - | $68.00K(-11.7%) |
Mar 2000 | - | $77.00K(-9.4%) |
Dec 1999 | $85.00K(-22.6%) | $85.00K(-22.7%) |
Sep 1999 | - | $110.00K(-99.6%) |
Jun 1999 | - | $26.10M(>+9900.0%) |
Mar 1999 | - | $103.40K(-5.8%) |
Dec 1998 | $109.80K(>+9900.0%) | - |
Dec 1998 | - | $109.80K |
Dec 1997 | $0.00 | - |
FAQ
- What is BioMarin Pharmaceutical Inc. annual long term debt?
- What is the all time high annual long term debt for BioMarin Pharmaceutical Inc.?
- What is BioMarin Pharmaceutical Inc. annual long term debt year-on-year change?
- What is BioMarin Pharmaceutical Inc. quarterly long term debt?
- What is the all time high quarterly long term debt for BioMarin Pharmaceutical Inc.?
- What is BioMarin Pharmaceutical Inc. quarterly long term debt year-on-year change?
What is BioMarin Pharmaceutical Inc. annual long term debt?
The current annual long term debt of BMRN is $626.39M
What is the all time high annual long term debt for BioMarin Pharmaceutical Inc.?
BioMarin Pharmaceutical Inc. all-time high annual long term debt is $1.12B
What is BioMarin Pharmaceutical Inc. annual long term debt year-on-year change?
Over the past year, BMRN annual long term debt has changed by -$4.82M (-0.76%)
What is BioMarin Pharmaceutical Inc. quarterly long term debt?
The current quarterly long term debt of BMRN is $596.16M
What is the all time high quarterly long term debt for BioMarin Pharmaceutical Inc.?
BioMarin Pharmaceutical Inc. all-time high quarterly long term debt is $1.17B
What is BioMarin Pharmaceutical Inc. quarterly long term debt year-on-year change?
Over the past year, BMRN quarterly long term debt has changed by +$2.05M (+0.34%)